Extract from the British Homeopathic Journal (2000) 89,174-177 Further information can be obtained from IDI, 5 St John's Lane. London. EC 1M 4BH. Tel: 020 7549 1642. Fax: 020 7549 1643 Case Study Recurrent Cold Sores Cold sores which recur can be just as debilitating as genital herpes. The following case demonstrates that the RNA/DNA/SNA formula 2LHERP is equally as effective for cold sores as it is for genital herpes. The formula contains two SNA which specifically target the two different Herpes viruses HSV1 and HSV2. A 50 yr old man went to consultation for recurrent cold sores. He had suffered from them for 5 yrs, initially l cold sore per year and then by the time that he consulted the homeopath he was getting 1 cold sore per month. After two months of treatment he no longer had any cold sores, neither during treatment nor after stopping treatment. To date he has been 18 months with no cold sores

Further information and Herpes case studies can be obtained from IDI at the above address. Combining 2LHERP with classical homeopathy By Dr Rosi Coerezza I usually combine most MicroImmunotherapy treatments with the patient's constitutional remedy. For genital herpes I always prescribe 2LHERP for preventing recurrences and advise external tea tree oil during any outbreaks. If there is also candida I often prescribe tea tree oil orally - 1 drop placed on a piece of sugar and swallowed. Local Doctor's Experience in a small French town Reported April 2002, Paris A local general practitioner in a small French town recently told us of his experience with 2LHERP. A patient came to see him who had been suffering from Herpes type 2 for the previous 2 years. She had seen all of the experts in the town, including the chief gynaecological consultant at the town's main hospital. Nothing worked. The doctor tried the patient on 2LHERP and within one month The patient showed great improvement. This produced a `petite revolution' in the town - the rumour spread quickly. After a few weeks the doctor received most of the town's herpes cases. Happy with the treatment success he decided to share it with the `officials' of the town including the hospital VIP's. He never got an answer. `But then this is France!' he shrugs.

People with AIDS or HIVhave used these herbal preparations for about two years, with mixed reports but no clear evidence of benefit. [For more background on hypericin, see coverage in AIDS TREATMENT NEWS, especially issues #63 (August 26, 1988), #91 (November 17, 1989), #96 (February 2, 1990), and #117 (December 21, 1990)].

A clinical trial using chemically synthesized hypericin could start as early as May at New York University Medical Center/Bellevue Hospital, the University of Minnesota at Minneapolis, and Boston Beth Israel Hospital. This trial was scheduled to start in the summer or fall of 1990, but was delayed by difficulties in preparing sufficient drug. Enough hypericin is now available.

For Complete Clinical study click here

a) Departamento de Patologia Clínica Veterinária, Laboratório de Virologia Veterinária, Universidade Federal do Rio Grande do Sul, 90540-000, Porto Alegre, RS, Brazil

b) Centro de Biotecnologia, Laboratório de Virologia Molecular, Universidade Federal do Rio Grande do Sul, 91501-970, Porto Alegre, RS, Brazil

c) Laboratorio de Farmacognosia, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Programa de pós-graduaçáo em Ciêncìas Farmacêuticas, Av. Ipiranga, 2752, 90610-000 Porto Alegre, RS, Brazil

Received 13 February 2001;
revised 11 July 2001;
accepted 17 July 2001.
Available online 29 August 2001.

For Complete Clinical study click here

Researchers writing in the July 1988 Proceedings of the National Academy of Sciences (abbreviated PNAS) suggested that hypericin, an active ingredient found in plants of the Hypericum family, commonly known as St. John's wort, might become a useful AIDS therapy.

The fact that the drug can be given by mouth, has already been used in humans, and is found in a widely available plant customarily used as a medicinal herb and sold at little cost, suggests that this treatment possibility might also be developed through the herbal and alternative-treatment traditions, avoiding the years of delay built into mainstream pharmaceutical development. But the herb must be used carefully, because large doses have poisoned grazing animals when they fed on it, and because many questions about its possible use as an AIDS treatment remain unanswered.

No human trials for HIV have yet been conducted. We have heard through guerilla clinic sources that several persons have started using the herb for this purpose, but they started only a few days ago, so it is too early to see any results.

For Complete Clinical study click here